According to Gram Research analysis, a 2026 genetic study of over 373,000 East Asian people found that higher vitamin D levels were associated with 19% lower COPD risk, while certain amino acids like leucine reduced risk by 44%. Conversely, elevated manganese levels and platelet counts increased COPD risk. These findings suggest that blood metabolites—chemicals produced during normal body processes—play a causal role in lung disease development in Asian populations, offering potential targets for prevention strategies.
A new genetic study of East Asian populations found that certain substances in the blood may help protect against COPD, a serious lung disease affecting millions of older adults. Researchers used advanced genetic analysis to study over 370,000 people and discovered that higher levels of vitamin D and certain amino acids (building blocks of protein) were linked to lower COPD risk. Interestingly, higher manganese levels and platelet counts appeared to increase risk. These findings are important because most previous research focused on European populations, and Asian people have different genetics and environmental exposures. The study suggests that monitoring and maintaining healthy levels of these blood chemicals could help prevent COPD in Asian communities.
Key Statistics
A 2026 Mendelian randomization study of 373,269 East Asian participants found that genetically predicted higher vitamin D levels were associated with 19% lower COPD risk (OR = 0.81, 95% CI 0.70-0.94, P = 0.0045).
The same 2026 study of East Asian populations found that leucine, an amino acid, was associated with 44% lower COPD risk (OR = 0.56, 95% CI 0.34-0.91, P = 0.0197).
In the 2026 East Asian genetic study, higher manganese levels were linked to 27% increased COPD risk (OR = 1.27, 95% CI 1.00-1.62, P = 0.0460), suggesting trace element metabolism influences lung disease.
A 2026 analysis of 7,332 COPD cases and 364,245 controls from East Asian biobanks found phosphoethanolamine, a phospholipid, was associated with 25% lower COPD risk and showed consistent protective effects across two independent datasets.
The Quick Take
- What they studied: Whether certain chemicals naturally found in blood cause or prevent COPD (a lung disease that makes breathing difficult) in East Asian people
- Who participated: Over 373,000 people from Japan and China, including about 7,300 with COPD and over 364,000 without the disease. Researchers used genetic information to trace which blood chemicals were linked to COPD risk.
- Key finding: Higher vitamin D levels were strongly protective against COPD (49% lower risk), and certain amino acids also reduced risk. However, higher manganese levels and platelet counts increased COPD risk in this population.
- What it means for you: If you’re of East Asian descent, maintaining healthy vitamin D levels and adequate protein intake may help protect your lungs. However, this is genetic research showing associations, not proof that supplements will prevent disease. Talk to your doctor about your individual risk factors.
The Research Details
This study used a sophisticated genetic method called Mendelian randomization, which is like a detective tool for finding cause-and-effect relationships using DNA. Instead of following people over time (which takes years), researchers used genetic variations that naturally occur in populations to predict who has higher or lower levels of specific blood chemicals. They then checked whether these genetic predictions matched COPD risk in two large Japanese databases containing information on thousands of people with and without the disease.
The researchers identified genetic markers (tiny variations in DNA) that reliably predicted blood levels of seven different metabolites—chemicals produced during normal body processes. These included vitamin D, amino acids like leucine, manganese, and others. By using these genetic markers as ‘instruments,’ they could determine whether these blood chemicals actually cause COPD or just happen to be associated with it.
This approach is powerful because genetics can’t be changed by lifestyle or disease, so it helps rule out reverse causation (where the disease causes the blood chemical change rather than the other way around). The study included sensitivity analyses—extra checks using different statistical methods—to ensure the findings were robust and not due to hidden biases.
Most COPD research has focused on European populations, but East Asian people have different genetic backgrounds and face different environmental exposures (like air pollution patterns and occupational hazards). This study fills an important gap by providing evidence specific to East Asian genetics. The findings suggest that metabolic factors—how the body processes nutrients and chemicals—may be a key mechanism in COPD development. Understanding these mechanisms could lead to new prevention strategies tailored to Asian populations.
This study has several strengths: it used very large sample sizes (over 370,000 people), employed rigorous genetic methods with multiple validation checks, and replicated findings across two independent datasets. The researchers tested for common sources of error and found none. However, the findings are ‘suggestive’ rather than definitive—some associations were borderline statistically significant. The study is observational at the genetic level, so it shows associations rather than absolute proof of causation. Results need confirmation in future studies and clinical trials.
What the Results Show
The study identified seven blood metabolites with potential causal links to COPD in East Asian populations. The most robust findings were for vitamin D and phosphoethanolamine (a type of fat molecule), which showed protective effects in both independent datasets studied. Specifically, genetically predicted higher vitamin D levels (measured as 25-hydroxyvitamin D2) were associated with 19% lower COPD risk. This was one of the strongest and most consistent findings in the study.
Amino acids also showed protective effects. Leucine (an amino acid important for muscle and immune function) was associated with 44% lower COPD risk, while alpha-aminoadipic acid showed 25% lower risk. These findings suggest that adequate protein metabolism and amino acid availability may be important for lung health.
On the risk side, higher genetically predicted manganese levels were associated with 27% increased COPD risk, and elevated platelet count (blood cells involved in clotting) showed 51% increased risk. Platelet count may reflect inflammation or other underlying processes that damage lungs.
Phosphoethanolamine, a phospholipid (fat-like molecule) important for cell membranes, showed 25% lower COPD risk and was one of only two findings that replicated consistently across both independent datasets, suggesting it may be particularly important.
The study also found that serum alanine transaminase (ALT), an enzyme related to liver function, was associated with 13% lower COPD risk. This suggests that metabolic health more broadly may influence lung disease risk. The researchers conducted extensive sensitivity analyses using different statistical methods, and the main findings held up, indicating they weren’t due to statistical artifacts or hidden biases. Tests for reverse causation (whether COPD causes the metabolite changes rather than vice versa) were negative, supporting the idea that these metabolites influence COPD risk rather than the disease changing metabolite levels.
This study is notable because it’s the first large-scale genetic study of metabolites and COPD in East Asian populations. Previous research on this topic was mostly conducted in European populations, which have different genetic structures and environmental exposures. The vitamin D finding aligns with some observational studies suggesting vitamin D deficiency is common in COPD patients, but this genetic approach provides stronger evidence for a causal relationship. The amino acid findings are relatively novel and suggest that protein metabolism deserves more attention in COPD research. The manganese finding is interesting because manganese exposure has been linked to lung disease in occupational settings, and this genetic evidence suggests even normal variation in manganese levels may matter.
The study has several important limitations. First, the findings are ‘suggestive’ rather than definitive—some associations had borderline statistical significance (P-values just below 0.05), meaning they could be due to chance. Second, Mendelian randomization assumes that genetic variations affect COPD only through the metabolite being studied, which may not always be true. Third, the study is observational and genetic, so it cannot prove that changing these metabolite levels will prevent COPD; clinical trials would be needed to test that. Fourth, the findings are specific to East Asian populations and may not apply to other ethnic groups. Finally, the study doesn’t explain the biological mechanisms—why these metabolites affect COPD risk—so more research is needed to understand how they work.
The Bottom Line
For East Asian populations: Maintain adequate vitamin D levels through sun exposure, diet, or supplementation if recommended by your doctor (moderate confidence). Ensure adequate protein intake to support amino acid metabolism (moderate confidence). Avoid excessive manganese exposure if possible, particularly in occupational settings (low confidence, based on this study alone). These recommendations should complement, not replace, standard COPD prevention strategies like avoiding smoking and air pollution. Consult your healthcare provider before starting supplements, especially if you have existing lung disease.
This research is most relevant to people of East Asian descent, particularly those with family history of COPD or risk factors like smoking history. It’s also important for public health officials and researchers working with Asian populations. Healthcare providers caring for Asian patients with COPD or at risk for it should consider these metabolic factors. The findings are less directly applicable to other ethnic groups, though some findings (like vitamin D) may be relevant more broadly. People with existing COPD should discuss these findings with their pulmonologist before making dietary changes.
If these metabolites do influence COPD risk, the protective effects would likely develop over years or decades, not weeks or months. COPD typically develops slowly over many years of exposure to risk factors. Maintaining healthy vitamin D and amino acid levels is a long-term strategy, not a quick fix. Any benefits would likely be seen in terms of slowing disease progression or reducing risk in people not yet diagnosed, rather than treating existing COPD.
Frequently Asked Questions
Does vitamin D prevent COPD?
Genetic research shows higher vitamin D levels are associated with 19% lower COPD risk in East Asian populations, suggesting a protective relationship. However, this is genetic evidence, not proof that supplements prevent disease. Clinical trials are needed to confirm whether vitamin D supplementation actually prevents COPD.
What amino acids are good for lung health?
This study found leucine and alpha-aminoadipic acid were associated with lower COPD risk in East Asian people. These amino acids come from protein-rich foods like meat, fish, eggs, beans, and dairy. Adequate protein intake supporting these amino acids may support lung health, though more research is needed.
Is manganese bad for your lungs?
This genetic study found higher manganese levels were associated with 27% increased COPD risk in East Asian populations. Manganese is essential in small amounts, but excessive exposure (particularly occupational) may harm lungs. Most people get adequate manganese from normal diet without health concerns.
Can I prevent COPD by changing my diet?
This research suggests maintaining adequate vitamin D and protein intake may reduce COPD risk, particularly in East Asian populations. However, diet alone cannot prevent COPD—avoiding smoking, air pollution, and occupational hazards are equally or more important. Consult your doctor about personalized prevention strategies.
Why is this study important for Asian people?
Most COPD research focused on European populations with different genetics and environments. This study of 373,000 East Asian people provides evidence specific to Asian genetic backgrounds, showing that metabolic factors like vitamin D and amino acids may be particularly important for lung health in Asian communities.
Want to Apply This Research?
- Track weekly vitamin D intake through food and supplements, and monitor sun exposure minutes. Set a target of 600-800 IU daily for adults (or as recommended by your doctor). Log protein intake at meals to ensure adequate amino acid availability.
- Add vitamin D-rich foods to your weekly meal plan (fatty fish, egg yolks, fortified milk). Increase protein intake to 0.8-1.0 grams per kilogram of body weight daily through varied sources. If supplementing vitamin D, track dosage and timing. Monitor any occupational or dietary manganese exposure and discuss with your doctor if concerned.
- Monthly review of vitamin D intake adequacy and protein consumption patterns. Quarterly check-ins with your healthcare provider about vitamin D levels if at risk for deficiency. Long-term tracking of respiratory symptoms and lung function (if available through your healthcare provider) to assess whether metabolic optimization correlates with lung health improvements.
This research presents genetic associations with COPD in East Asian populations and does not constitute medical advice. The findings are suggestive rather than definitive proof of causation. Do not start, stop, or change any supplements or medications based on this research without consulting your healthcare provider. If you have COPD or respiratory symptoms, work with a pulmonologist or respiratory specialist. Genetic studies show associations that require clinical trials to confirm whether interventions actually prevent disease. Individual risk factors vary; your doctor can assess your personal COPD risk and recommend appropriate prevention strategies.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.